2025-03-22 01:00:19
Latest Post
Hindustan Zinc recycles more than 18 billion litres of water, equivalent to water consumption of 1 lakh households
IHCL hotels in Delhi-NCR celebrate triple milestone of environmental stewardship
Ahead of the IPL season, Airtel augments its network at the Chepauk Stadium
Lemon Tree Hotels signs two new properties in Vrindavan and in Navsari
DAM Capital Advisors Limited receives warning and deficiency letter from SEBI
Stock Report
Supriya Lifescience Ltd Q3 FY2025 PAT up at Rs. 46.78 crores
Posted On : 2025-01-27 20:24:14( TIMEZONE : IST )
Supriya Lifescience Limited has reported Standalone financial results for the period ended December 31, 2024.
Financial Results (Q3 FY2025) - QoQ Comparison
The company has reported total income of Rs. 187.745 crores during the period ended December 31, 2024 as compared to Rs. 168.620 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs. 46.783 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs. 46.149 crores for the period ended September 30, 2024.
The company has reported EPS of Rs. 5.82 for the period ended December 31, 2024 as compared to Rs. 5.71 for the period ended September 30, 2024.
| Financials | Q3 FY2025 | Q2 FY2025 | % Change |
| Total Income | ₹ 187.745 crs | ₹168.620 crs |  11.34% |
| Net Profit | ₹46.783 crs | ₹46.149 crs | 1.37% |
| EPS | ₹5.82 | ₹5.71 | 1.93% |
Financial Results (Q3 FY2025) - YoY Comparison
The company has reported total income of Rs. 187.745 crores during the period ended December 31, 2024 as compared to Rs.143.139 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs.46.783 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs.29.787 crores for the period ended December 31, 2023.
The company has reported EPS of Rs.5.82 for the period ended December 31, 2024 as compared to Rs.3.70 for the period ended December 31, 2023.
| Financials | Q3 FY2025 | Q3 FY2024 | % Change |
| Total Income | ₹ 187.745 crs | ₹143.139 crs | 31.16% |
| Net Profit | ₹46.783 crs | ₹29.787 crs | 57.06% |
| EPS | ₹5.82 | ₹3.70 | 57.30% |
Financial Results (9 Months Ended FY2025) - YoY Comparison
The company has reported total income of Rs.519.216 crores during the 9 Months period ended December 31, 2024 as compared to Rs.420.639 crores during the 9 Months period ended December 31, 2023.
The company has posted net profit / (loss) of Rs.137.576 crores for the 9 Months period ended December 31, 2024 as against net profit / (loss) of Rs.82.182 crores for the 9 Months period ended December 31, 2023.
The company has reported EPS of Rs.17.07 for the 9 Months period ended December 31, 2024 as compared to Rs.10.21 for the 9 Months period ended December 31, 2023.
| Financials | 9 Months Ended FY2025 | 9 Months Ended FY2024 | % Change |
| Total Income | ₹519.216 crs | ₹420.639 crs | 23.44% |
| Net Profit | ₹137.576 crs | ₹82.182 crs | 67.40% |
| EPS | ₹17.07 | ₹10.21 | 67.19% |
Shares of Supriya Lifescience Limited was last trading in BSE at Rs. 700.80 as compared to the previous close of Rs. 729.45. The total number of shares traded during the day was 24237 in over 1518 trades.
The stock hit an intraday high of Rs. 745.95 and intraday low of 680.00. The net turnover during the day was Rs. 17395122.00.
